Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA small bruise at your injection site after a Mounjaro dose is common and usually nothing to worry about. Most people who notice bruises from Mounjaro are seeing the result of a tiny blood vessel being nicked by the needle — not the medicine itself causing a problem. The bruise typically fades within a few days. That said, knowing what's genuinely normal versus a sign you should call someone is worth understanding properly, so here's the full picture. Mounjaro (tirzepatide) is a prescription-only medicine; any concerns about your reaction to it should go to your prescribing team first.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You pressed the KwikPen firmly against your skin, heard the click, held it for the count, and when you lifted it away there was already a faint purple mark forming. This is probably the most common thing our prescribers hear about in the first few weeks of treatment. It isn't alarming, but it is annoying when you weren't expecting it.
The bruise appears because the needle (fine as it is) has passed through skin that contains a network of small capillaries. Clip one, and a tiny bleed pools under the surface. The medicine tirzepatide itself isn't making blood vessels fragile; the injury is purely mechanical. Tirzepatide is a dual GIP and GLP-1 receptor agonist working on appetite and blood-sugar pathways, not on clotting or vessel walls in healthy adults.
Most injection-site bruises are smaller than a five-pence piece, blue-purple at first, yellow-green as they resolve, and gone within three to seven days. The Mounjaro patient information leaflet lists injection-site bruising as a known side effect, so you're in well-documented company. It tends to be more noticeable in the first weeks, before you've settled into a reliable technique.
Small changes in how you inject can cut the frequency and size of bruises noticeably. First: site rotation. Injecting the same spot on your abdomen every week means you're returning to tissue that's already been disturbed. Stagger your sites, different quadrant of the abdomen, or alternate between abdomen, outer thigh, and upper arm across your weekly doses.
Second: let the pen do its full job. The KwikPen clicks when the dose starts and again when it's done. Withdrawing before that second cue (or lifting the pen too sharply) can drag on the tissue and increase the chance of a small bleed. Hold it steady and straight throughout.
Third: temperature and tension. Cold skin bruises more readily; if you keep your pen refrigerated, the medicine inside will be chilled. Some people find injecting into slightly warmed, relaxed skin (not massaged immediately before, which can spread a small bleed) produces a cleaner entry. Don't rub the site vigorously afterwards. You can read about bruising patterns in more detail on the Mounjaro bruise page, including how the colour changes as it heals.
Blood thinners and anticoagulants are worth mentioning to your prescriber: if you're taking anything in that class, bruising from any injection is likely to be more pronounced and slower to clear. Same applies to high-dose aspirin or NSAIDs used regularly.
A purple patch the size of a coin that appears within seconds of your injection: routine. A bruise that spreads across a wide area over the next 24 hours, or one that appears on days when you haven't injected at all: not routine. The question of whether Mounjaro makes you bruise more easily overall (beyond injection sites) is a separate clinical issue that warrants a conversation with your GP or prescribing team rather than an assumption it'll resolve on its own.
Similarly, if the bruised area becomes hot, swollen, increasingly painful, or develops any discharge, that suggests infection rather than a simple bleed. Get medical advice promptly if that happens. Side effects you're unsure about (including any that feel unusual or disproportionate) can also be reported to the MHRA via the Yellow Card scheme, which is how the UK gathers real-world safety data on medicines including tirzepatide.
The NHS medicines guidance for tirzepatide outlines the full side-effect profile; it's worth a read if you want the complete picture of what's monitored. Separately, if you're thinking about cost alongside all of this, our Mounjaro price page explains what's included in treatment and how pricing works in the private market.
A handful of people find injection-site bruising uncomfortable enough to question whether they want to continue. That's a reasonable thing to feel, particularly if you're already navigating nausea in the early weeks. The experience tends to improve as technique becomes second nature and the body adjusts to the weekly routine.
If the bruising is genuinely bothering you or if you've noticed bruising after Mounjaro that looks different from the typical small post-injection mark, the right move is to raise it with your prescriber rather than quietly stopping. Dose adjustments, site changes, or a review of any other medicines you're taking can all be relevant. Our clinical team (you can find out more on the clinical team page) reviews every patient's treatment before each repeat, which is exactly the kind of thing that gets flagged and discussed properly at that point. If bruising is your main concern right now, starting that conversation costs nothing: begin a free consultation and our prescribers can address it as part of your assessment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.